64 results
8-K
AXDX
Accelerate Diagnostics Inc
25 May 21
Departure of Directors or Certain Officers
4:10pm
of certain annual revenue and operational milestone targets no later than the end of 2023. If such targets are not achieved by the end of 2023
8-K
EX-99.2
AXDX
Accelerate Diagnostics Inc
26 Jan 01
Current report
12:00am
screening to accelerate discovery of new drugs and
drug targets; genetic identification for medical predisposition, susceptibility,
profiling
8-K
EX-99.3
AXDX
Accelerate Diagnostics Inc
27 Dec 00
Current report
12:00am
to accelerate discovery of new drugs and
drug targets; genetic identification for medical predisposition, susceptibility,
profiling, therapeutic design
8-K
AXDX
Accelerate Diagnostics Inc
27 Dec 00
Current report
12:00am
of human and animal
diseases, and high throughput screening to accelerate discovery of new drugs and
drug targets.
Consideration to be paid by Accelr8
8-K
EX-99.1
d7s6zpjxb129p
18 Aug 20
Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Antibody Testing System
5:10pm
8-K
gknj9edwxtz86eyohmo
15 Aug 22
Entry into a Material Definitive Agreement
4:32pm